Home › Trial NCT01411319
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer
- Trial IDNCT01411319
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of Miami
- Enrollment25
- Start date2011-12-27
- ConditionsProstate Cancer · Prostate Adenocarcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.